Literature DB >> 16643434

High glucose levels enhance platelet activation: involvement of multiple mechanisms.

Dzana Sudic1, Masoud Razmara, Mikael Forslund, Qiushang Ji, Paul Hjemdahl, Nailin Li.   

Abstract

Diabetes mellitus (DM) and hyperglycaemia are associated with platelet activation. The present study was designed to investigate how high glucose levels influence platelet function. Fasting human blood was incubated with different concentrations of D-glucose (5, 15 and 30 mmol/l) and other sugars without or with in vitro stimuli. Platelet activation was monitored by whole blood flow cytometry. High glucose levels enhanced adenosine diphosphate (ADP)- and thrombin receptor-activating peptide (TRAP)-induced platelet P-selectin expression, and TRAP-induced platelet fibrinogen binding. Similar effects were seen with 30 mmol/l L-glucose, sucrose and galactose. Hyperglycaemia also increased TRAP-induced platelet-leucocyte aggregation. Protein kinase C (PKC) blockade did not counteract the enhancement of platelet P-selectin expression, but abolished the enhancement of TRAP-induced platelet fibrinogen binding by hyperglycaemia. Superoxide anion scavenging by superoxide dismutase (SOD) attenuated the hyperglycaemic enhancement of platelet P-selectin expression, but did not counteract the enhancement of TRAP-induced platelet fibrinogen binding. Hyperglycaemia did not alter platelet intracellular calcium responses to agonist stimulation. Blockade of cyclo-oxygenase (COX), phosphotidylinositol-3 (PI3) kinase, or nitric oxide synthase, or the addition of insulin did not influence the effect of hyperglycaemia. In conclusion, high glucose levels enhanced platelet reactivity to agonist stimulation through elevated osmolality. This occurred via superoxide anion production, which enhanced platelet P-selectin expression (secretion), and PKC signalling, which enhanced TRAP-induced fibrinogen binding (aggregablity).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643434     DOI: 10.1111/j.1365-2141.2006.06012.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

Review 1.  Platelet activation, and antiplatelet targets and agents: current and novel strategies.

Authors:  Yao-Zu Xiang; Ye Xia; Xiu-Mei Gao; Hong-Cai Shang; Li-Yuan Kang; Bo-Li Zhang
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.

Authors:  Masafumi Ueno; Kosuke Fujita; Hiroyuki Yamamoto; Tomoyuki Ikeda; Tatsuya Suga; Kenji Yamaji; Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Dominick J Angiolillo; Shunichi Miyazaki
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

3.  Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.

Authors:  Damien J Lapar; Vanessa A Hajzus; Yunge Zhao; Christine L Lau; Brent A French; Irving L Kron; Ashish K Sharma; Victor E Laubach
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-06       Impact factor: 6.914

4.  Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?

Authors:  Wilson Ong; Tong Shen; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

Review 5.  Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia.

Authors:  Ricardo A Perez de la Hoz; Sandra Patricia Swieszkowski; Federico Matias Cintora; Jose Martin Aladio; Claudia Mariana Papini; Maia Matsudo; Alejandra Silvia Scazziota
Journal:  Eur Cardiol       Date:  2018-08

Review 6.  Effect of perioperative glucose-insulin-potassium infusions on mortality and atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis.

Authors:  Doreen Rabi; Fiona Clement; Finlay McAlister; Sumit Majumdar; Reg Sauve; Jeffrey Johnson; William Ghali
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

7.  Increased platelet activation in sleep apnea subjects with intermittent hypoxemia.

Authors:  Ana C Krieger; Ranjini Anand; Evelyn Hernandez-Rosa; Allison Maidman; Sara Milrad; Miles Q DeGrazia; Alexander J Choi; Clara Oromendia; Aaron J Marcus; Joan H F Drosopoulos
Journal:  Sleep Breath       Date:  2020-02-08       Impact factor: 2.816

8.  Glycemia, triglycerides and disease severity are best associated with higher platelet activity in patients with stable coronary artery disease.

Authors:  Pavel P Osmancik; Frantisek Bednar; Heidi Móciková
Journal:  J Thromb Thrombolysis       Date:  2007-02-17       Impact factor: 2.300

9.  Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.

Authors:  L M Steffen; M Cushman; J M Peacock; S R Heckbert; D R Jacobs; W D Rosamond; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

10.  Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.

Authors:  Zequan Yang; Victor E Laubach; Brent A French; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01-18       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.